To discuss the findings of Putri et al. regarding long-term outcomes in children with metabolically healthy obesity (MHO) and to highlight methodological considerations.
Approach:
Observation Period: The letter emphasizes the need for a longer observation period to fully understand the progression of cardiometabolic disease in individuals categorized as MHO.
BMI Z Score Reduction: It questions the clinical significance of a 0.25 reduction in body mass index z score as a measure of favorable response and suggests exploring a dose-response relationship.
Metabolic Health Dynamics: The letter points out that metabolic health is not static and that without serial assessments, it is unclear how many MHO participants transitioned to an unhealthy phenotype.
Key Findings:
The follow-up period ended at a median age of 19.5 years, which may not capture the full burden of cardiometabolic disease, particularly as progression is often recognized later in life.
A reduction of 0.25 in BMI z score may not adequately reflect clinical significance or risk stratification, and the authors question whether a dose-response relationship exists.
The lack of serial metabolic assessments limits understanding of how many MHO participants transitioned to an unhealthy phenotype over time.
Interpretation:
The authors argue for the need to reconsider how metabolic health is assessed and monitored in pediatric populations with obesity, emphasizing the dynamic nature of metabolic health.
Limitations:
The study's follow-up period may not be sufficient to observe long-term health outcomes.
The clinical significance of the BMI z score reduction is not clearly established.
Lack of serial assessments prevents understanding of changes in metabolic health status.
Conclusion:
The letter highlights the need for more nuanced clinical assessments in pediatric obesity and the importance of early intervention.
